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GenderObjective: Our population-based study examined the prevalence of insomnia symptoms and its sociode-
mographic, subjective, and polysomnographic (PSG) sleep risk factors in young and preadolescent chil-
dren.
Methods: We performed a cross-sectional study of 700 children, ages 5–12 years who underwent a 9-h
PSG and parent-completed sleep and development questionnaires (Penn State Child Cohort). Insomnia
symptoms were deﬁned as parent report of difﬁculty falling or staying asleep and sleep-disordered
breathing (SDB) as an apnea hypopnea index of P1.
Results: The prevalence of insomnia symptoms was 19.3% and did not signiﬁcantly change (20.2%) when
children with SDB were excluded. A signiﬁcant interaction between gender and age revealed that the
prevalence of insomnia symptoms was highest in girls ages 11 to 12 years (30.6%). This gender difference
was not associated with signiﬁcant differences between girls and boys ages 11–12 years in anxiety and
depressive symptoms. In contrast girls ages 11–12 years with insomnia symptoms, but not boys of the
same group, demonstrated clinically signiﬁcant PSG sleep disturbances compared to those without
insomnia symptoms.
Conclusions: These data suggest that one out of ﬁve young children and preadolescents of the general
population have insomnia symptoms. Importantly, the prevalence of insomnia symptoms peaks in girls
ages 11 to 12 years and is associated with objective sleep disturbances which may be related to hormonal
changes associated with the onset of puberty rather than anxiety and depression.
 2013 The Authors. Published by Elsevier B.V. All rights reserved.1. Introduction
There is increasing recognition that sleep disturbances are
important factors in child development. When children do not
get enough sleep, aspects of their physical, emotional, cognitive,
and social development are negatively affected and can impair
both the parent and child’s daytime functioning. It has been re-
ported that approximately 40% of all children experience sleep
problems, yet compared to adults, sleep disturbances including
symptoms of insomnia in childhood are poorly studied and
described.Insomnia symptoms have been investigated in several commu-
nity and clinical samples of young children and adolescents but
have been idiosyncratically deﬁned with differences in inclusion
criteria, which makes comparisons across studies difﬁcult. Conse-
quently, prevalence estimates of insomnia symptoms in childhood
have varied from 4% to 41% [1–9]. Insomnia symptoms of difﬁculty
falling (DFA) and/or staying asleep (DSA) are the most common
parent-reported sleep complaints in children, but little is known
about the risk factors associated with insomnia symptoms in pre-
pubescent children, with the exception of two population-based
studies in China of children ages 6–13 years [3,10]. These studies
did not ﬁnd age or gender effects on the prevalence of insomnia
symptoms. In contrast, a few studies on the risk factors associated
with insomnia symptoms in adolescents have reported an increase
in the prevalence of insomnia symptoms with age, [7,11] and an in-
crease in the prevalence of insomnia symptoms in girls following
menarche [4,8]. One study [4] reported a gender and age effect,
with signiﬁcantly increased risk for self-report of insomnia symp-
toms following onset of menses in girls ages 11–14 years, and
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ported a 2.75 fold increased risk for insomnia following onset of
menses in girls.
Although there is substantial published literature examining
insomnia symptoms and its correlates in older adolescents and
adults [12–18], as well as in children with psychiatric and medical
problems such as autism [19], attention-deﬁcit/hyperactivity dis-
order [20], and gastrointestinal regurgitation and headaches [2],
few studies have been conducted on insomnia symptoms in young
children and preadolescents from the US general population, and
none assessing the risk factors of body mass index (BMI), PSG sleep
disturbance, and anxiety and depressive symptoms on the preva-
lence of insomnia symptoms and the role of excessive daytime
sleepiness (EDS) and objectively measured SDB. Thus the objec-
tives of our study were to (1) report on the prevalence of insomnia
symptoms and type of insomnia complaint in a general population
sample of young children and preadolescents, (2) identify differ-
ences in objective sleep disturbance as measured with PSG in chil-
dren with and without insomnia and (3) assess the effect of risk
factors (e.g., gender, age, BMI, anxiety, depressive symptoms) and
EDS and SDB, which have been demonstrated to be important in
adult populations, on the prevalence of insomnia symptoms in
the Penn State Child Cohort.2. Methods
2.1. Sample
Our study was designed in 2 phases, with the ﬁrst phase de-
signed for collecting general information from the parents about
their child’s sleep and behavioral patterns. In the ﬁrst phase, each
grade in elementary schools (kindergarten through grade 5) with
approximately 1500 students were selected. To establish a repre-
sentative sample, a screening questionnaire based on the survey
published by Ali et al. [21] was sent home to parents of every stu-
dent in these school districts. Over the course of 5 years, we as-
sessed all 18 public elementary schools within 3 school districts.
We sent home 7312 questionnaires; 5740 were returned for a
78.5% response rate. The second phase of our study was initiated
each year by randomly selecting 200 children based on a stratiﬁca-
tion of grade, sex, and risk for SDB from the returned question-
naires from the current year. We studied 704 children in this
phase for a total response rate of 70.4%. Four children did not com-
plete the PSG recording; thus 700 children were included in our
study for a ﬁnal response rate of 70%. We contrasted the subjects
who completed the PSG recordings (n = 700) with those who com-
pleted the phase 1 questionnaire (n = 5040) and were not selected
for phase 2. There were no signiﬁcant differences between the two
groups in gender, age, grade, BMI percentile, ethnicity, or race. We
established compensatory weights to obtain estimates of the origi-
nal target population and adjusted for the age and gender distribu-
tion of the nation as a whole. Please refer to our previous
publications for further details regarding the sampling methods
used in the Penn State Child Cohort [e.g., 22]. Thus our ﬁnal sample
for this study consisted of 700 children. The study was approved by
the Institutional Review Board of Penn State College of Medicine.
Informed consent was obtained from parents of all participants
and assent was obtained from all children prior to participation.2.2. Sleep laboratory
During their visit in the laboratory, all subjects underwent a
series of subjective and objective measurements including par-
ent-completed questionnaires and rating scales (e.g., behavior,
sleep, child development) and measurement of height and weightwere recorded for each child. BMI was calculated and expressed as
BMI percentiles (BMI %), adjusted for age and gender using the for-
mula and data of the National Health and Nutrition Examination
Survey Centers for disease control and prevention growth charts
[23].
All children underwent a 9-h PSG with a parent present in a
sound-attenuated light- and temperature-controlled room in our
General Clinical Research Center. Children’s bedtime and waketime
approximated their typical sleep times (average 2100–2200 to
0600–0700). Each child was monitored with an infrared video and
a computerized system (24 analog channel and 10 dc channel TS
ampliﬁer using Gamma software, Grass Telefactor, Inc.), including
four channels of electroencephalogram, two channel bilateral elec-
trooculogram, and chin and anterior tibial electromyogram. Respi-
ration was assessed throughout the night by use of a thermocouple
at the nose and mouth (model TCT R, Grass Telefactor, Inc), nasal
pressure (MP 45–871 + 2 cm H2O, Validyne Engineering Corp),
and Piezo thoracic and abdominal respiratory effort electric belts
(model 1312, Sleepmate). We obtained an objective estimate of
snoring during the PSG by monitoring breathing sounds with a
microphone attached to the throat (model 1250, Sleepmate Tech-
nologies) and a separate room microphone. All night hemoglobin
oxygen saturation was obtained by pulse oximeter (model 8800,
Nonin Medical) attached to the ﬁnger. A single channel electrocar-
diogram also was recorded. All of the PSG records were double
scored in accordance with a modiﬁed version of the American Tho-
racic Society standards for cardiopulmonary sleep studies in chil-
dren [24]. These modiﬁcations included the addition of breathing-
related arousals and elimination of central apneas in the calculation
of the apnea-hypopnea index (AHI). Results from the overnight PSG
evaluation were used to classify the children as having or not hav-
ing SDB. Obstructive apnea was deﬁned as a cessation of airﬂow
with a minimum duration of 5 s and an out of phase strain gauge
movement. A hypopneic event was deﬁned as a reduction of airﬂow
of approximately 50% with an associated decrease in oxygen satu-
ration of at least 3% or an associated breathing related arousal.
Based on these data an AHI was calculated ([apnea + hypopnea]/
hours of sleep). Central apneas were not included in the AHI calcu-
lation. The scoring of snoring was based on the number of snoring-
related arousals counted by the technician. SDB was deﬁned as an
AHIP 1 events per hour of sleep.
2.3. Parent rating scales
One of the key determinants of insomnia in children as deﬁned
by the International Classiﬁcation of Sleep Disorders is difﬁculty fall-
ing asleep, staying asleep, or both, as reported by the parent. In our
study, we deﬁned insomnia in a similar manner. A parent com-
pleted the Pediatric Behavior Scale (PBS) [25], a 165-item rating
scale which has norm-referenced T scores for several subscales
including problems with sleep. Each item is scored on a 0–3 point
scale, with 0 indicating no problems and 3 indicating that a behav-
ior is very often a problem. Children were classiﬁed as having
insomnia symptoms within the past 2 months when the parent re-
ported often or very often for either has trouble falling asleep or
wakes up often in the night. In addition, parents rated their child
on two additional subscales from the PBS related to anxiety and
depressive symptoms. The PBS has been used in several studies
by our group to assess sleep problems in children with autism
and attention-deﬁcit/hyperactivity disorder, as well as in the gen-
eral population [2,19,20,26].
The Pediatric Sleep Questionnaire developed by Chervin [27]
was completed by a parent to assess EDS in our study population.
Children were classiﬁed as having EDS when the parent reported
yes for either ‘‘Does your child have a problem with sleepiness dur-
ing the day?’’ or ‘‘Has a teacher or other supervisor commented
Table 1
Demographic polysomnographic sleep characteristics and subjective report of sleep
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tion of EDS was used in several recently published studies [28–30].and mood problems of preadolescent children with and without insomnia.
No insomnia
(n = 565)
Insomnia
(n = 135)
P value
Sociodemographics
Age 8.8 ± 1.8 8.8 ± 1.7 .94
BMI percentile 60.9 ± 30.6 61.2 ± 28.7 .84
% Male 45.5 48.3 .62
% Nonprofessional 46.6 44.2 .70
% Minority 19.6 17.9 .98
PSG characteristics
SL (min) 28.1 ± 23.5 33.1 ± 26.0 .04
REML 164.2 ± 86.6 148.1 ± 56.6 .04
TST (min) 453.7 ± 49.8 453.3 ± 44.6 .85
SE (%) 85.9 ± 8.6 85.8 ± 8 .97
Stage 1 (%) 3.5 ± 3.3 3.3 ± 3 .56
Stage 2 (%) 45.6 ± 11.6 48.7 ± 9.7 .002
SWS (%) 31.1 ± 11.1 27.5 ± 8.8 <.001
REM (%) 19.9 ± 5.7 20.6 ± 5.4 .16
AHI 0.85 ± 1.7 0.72 ± 1.1 .52
Subjective sleep
% DFA only – 44.7 –
% DSA only – 26.0 –
% Both DFA & DSA – 29.3 –
% EDS 11.7 21.4 .001
Mood
Anxiety (T) 50.4 ± 11.0 56.9 ± 14.1 <.001
Depression (T) 50.6 ± 12.6 58.5 ± 19.8 <.001
Abbreviations: BMI, body mass index; SL, sleep latency; REML, REM latency; TST,
total sleep time; SE, sleep efﬁciency; SWS, slow-wave sleep; AHI, apnea-hypopnea
index; EDS, excessive daytime sleepiness; DSA, difﬁculty staying asleep; DFA, dif-
ﬁculty falling sleep.
352.4. Data analysis
The v2 test was used for categorical data and analyses of vari-
ance were used for continuous variables between children with
and without insomnia symptoms. The prevalence of insomnia
symptoms was calculated in two ways: for the total sample and
when excluding all children with SDB (AHIP 1). Logistic regres-
sion analysis was used to examine the level of interaction between
age and gender while controlling for BMI, AHI, anxious and depres-
sive symptoms, and medical complaints [2]. Based on the results of
this interaction, we compared girls and boys 11–12 years of age on
key variables such as anxiety, depression, EDS, and BMI; we also
assessed 9 objective sleep variables, including AHI; total sleep time
in minutes; sleep latency in minutes; rapid eye movement (REM)
sleep latency (minutes from sleep onset to REM sleep); sleep efﬁ-
ciency (time asleep divided by total time in bed); and percentages
of stages 1, 2, slow-wave sleep, and REM sleep. Furthermore, we
conducted gender speciﬁc analyses comparing girls ages 11–
12 years with and without insomnia symptoms on objective mark-
ers of sleep and then separately for boys ages 11–12 years with and
without insomnia symptoms. We accounted for the sampling prob-
ability from phase 1 to phase 2 enrolments in all the analyses to
generate population level estimates and to make inferences back
to the population from which the phase 2 study participants were
selected. All variables were normally distributed. With the excep-
tion of 9 missing cases for the total sample on parent reported anx-
iety and depression symptoms, complete data were available on all
variables. The signiﬁcance level was set at P < .05. Analyses were
performed using PASW software, version 20.0 
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Fig. 1. Prevalence of insomnia by gender and age groups. Interaction between age
and gender on insomnia prevalence was statistically signiﬁcant (P = .03).3. Results
The demographic PSG sleep characteristics and subjective report
of sleep and mood problems comparing children with and without
insomnia symptoms are presented in Table 1. The prevalence of
insomnia symptoms was 19.3% and did not signiﬁcantly change
(20.2%) when children with SDB (n = 183) were excluded. Within
insomniacs, parents reported that 44.7% had DFA, 26.0% had DSA,
and 29.3% had both. There were no signiﬁcant differences between
girls (20.0%) and boys (18.3%) or across age groups of 5–7, 8–10,
and 11–12 years (21.2%, 16.5%, and 24.3%, respectively) in the prev-
alence of insomnia symptoms. PSG markers of sleep suggested that
children with insomnia symptoms, as previously reported [2], had
signiﬁcantly increased sleep latency and stage 2 sleep, and
decreased slow-wave sleep and REM sleep latency compared to
children without insomnia symptoms. Children with insomnia
symptoms had signiﬁcantly more parent-reported symptoms of
anxiety and depression (P = .001) and EDS (P = .001) than children
without. When children with SDB were excluded from the analysis,
anxiety and depression remained signiﬁcant (P < .001), while EDS
became non signiﬁcant (P = .22). These excluded children with SDB
were signiﬁcantly heavier than the remaining children without
SDB (BMI percentile, 65.4 ± 28.8 vs 59.5 ± 28.9; P = .019).
Logistic regression analysis revealed a signiﬁcant interaction be-
tween age (5–10 vs 11–12 years) and gender on the prevalence of
insomnia symptoms (P = .03). Speciﬁcally, girls ages 11–12 years
showed a signiﬁcantly higher prevalence of insomnia symptoms
(30.6%) compared to girls ages 5–7 (20.8%) or 8–10 years (16.3%),
whereas the prevalence of insomnia symptoms in boys was similar
across all age groups (i.e., 5–7 [21.9%]; 8–10 [17.3%], or 11–12 years
[16.7%]) as reported in Fig. 1. The signiﬁcant interaction between
age and gender on the prevalence of insomnia symptoms remainedthe same, even after controlling for BMI, AHI, anxiety and depres-
sion, sleep efﬁciency, and medical complaints (P = .01) In contrast,
a two-way analysis of variance did not show a signiﬁcant interac-
tion between gender and age on anxiety and depression scores
(gender effect, P = .40; age effect, P = .002; interaction, P = .39) or
on other key clinical factors (see Supplementary Table 1).Therefore,
no gender differences were found when comparing boys and girls
ages 11–12 years on anxiety and depression scores or in BMI
percentile, SDB, EDS, or PSG characteristics, with the exception of
girls having slightly less % stage 1 and more % REM sleep than boys
(Table 2). In addition, no gender differences were found when
Table 2
Gender differences in children age 11–12 years old.
Girls
(n = 62)
Boys
(n = 56)
P value
PSG measures
SL (min) 30.1 ± 18.2 31.8 ± 23.3 .17
REML 150.9 ± 74.2 167.9 ± 64.3 .54
TST (min) 456.3 ± 38.1 453.3 ± 52.3 .17
SE (%) 86.8 ± 6.6 84.8 ± 8.3 .11
Stage 1 (%) 2.6 ± 2.7 4.2 ± 3.3 .001
Stage 2 (%) 51.0 ± 9.5 51.7 ± 10.0 .51
SWS (%) 24.8 ± 8.8 25.0 ± 9.4 .91
REM (%) 21.6 ± 5.3 19.0 ± 5.7 .006
% AHIP 1 25.0 38.7 .12
Subjective sleep
% DFA only 16.1 13.1 .47
% DSA only 3.6 1.6 .42
% Both DFA & DSA 10.7 1.6 .03
% EDS 10.7 12.9 .71
Mood
Anxiety (T) 50.0 ± 12.6 50.3 ± 10.3 .98
Depression (T) 52.5 ± 14.5 52.3 ± 19.3 .70
Abbreviations: PSG, polysomnography; SL, sleep latency; REML, REM latency; TST,
total sleep time; SE, sleep efﬁciency; SWS, slow-wave sleep; AHI, apnea-hypopnea
index; EDS, excessive daytime sleepiness; DSA, difﬁculty staying asleep; DFA, dif-
ﬁculty falling sleep.
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aforementioned variables (see Supplementary Tables 2 and 3).
Finally, gender-speciﬁc analyses showed that girls ages 11–
12 years with insomnia symptoms (n = 19) had signiﬁcantly longer
PSG sleep latency (40.4 ± 22.9 vs 24.2 ± 12.5 min; P < .001), lower
sleep efﬁciency (84.3 ± 6.1 vs 88.2 ± 5.9; P = .017) and a trend to-
wards shorter sleep duration (447.0 ± 35.9 vs 461.7 ± 38.5 min;
P = .12) than girls ages 11–12 years without insomnia symptoms
(n = 43). In contrast, no signiﬁcant differences were found between
boys ages 11–12 years with and without insomnia symptoms on
any PSG markers of sleep.4. Discussion
Our study demonstrates that approximately one-ﬁfth of young
and preadolescent children from the general population have
insomnia symptoms. Moreover, our study showed that the preva-
lence of insomnia symptoms was highest in girls aged 11–12 years
and was associated with objective sleep disturbances. Interest-
ingly, this higher prevalence in girls was not associated with in-
creased anxiety, depression, or SDB, but with objective sleep
disturbance. Our novel ﬁndings suggest that the increased preva-
lence of insomnia symptoms in girls during the peripubertal stage
of development may reﬂect biologic and psychosocial changes
associated with this developmental stage.
Consistent with previous studies [4,6], the prevalence of insom-
nia symptoms in our population-based cohort was 19.3%, with DFA
being the most frequent type of insomnia complaint (44.7%). Over-
all, insomnia symptoms were associated with greater reports of
anxiety and depressive symptoms which is consistent with previ-
ous studies in young children [31], older adolescents, and adults
[14,31–35]. To our knowledge, our study is the ﬁrst study to report
on objective measures of sleep, as assessed by PSG, in a population
sample of young children and preadolescents with and without
insomnia symptoms. We found that children with insomnia symp-
toms had signiﬁcantly poorer objective sleep compared to children
without insomnia overall. However, the magnitudes of the differ-
ences in PSG parameters were relatively small, which suggests that
some children slept objectively better than others, even within
those with parent-reported insomnia symptoms. Future studiesshould examine the association between the degree of objective
sleep disturbance and clinically meaningful outcomes (e.g., behav-
ioral and mood problems, stress system activation, blood pressure)
in young children and preadolescents with insomnia symptoms.
Importantly, we found a signiﬁcant interaction between gender
and age on the prevalence of insomnia symptoms. The prevalence
of insomnia symptoms was 10–14% higher in girls in the peripu-
bertal stage of development (i.e., ages 11–12 years) as compared
to girls ages 5–7 (20.8%) or 8–10 years (16.3%) or to boys in any
of these age groups (19%), a ﬁnding that is consistent with a pre-
vious study reporting a similar prevalence of insomnia symptoms
in girls aged 11–14 years old (30%) [4]. In contrast, we did not ﬁnd
a signiﬁcant interaction between gender and age on anxiety and
depressive symptoms, and therefore no signiﬁcant differences be-
tween boys and girls aged 11–12 years in anxiety and depression.
In fact, anxiety and depressive symptoms increased at ages 8–10
years and reached a plateau regardless of gender. These data sug-
gest that the increased prevalence of insomnia symptoms in pread-
olescent girls is not likely explained by an increase in anxiety and
depression per se and that other factors may play a role, e.g., bio-
logic changes associated with puberty. Consistent with this
hypothesis is the fact that we found clinically signiﬁcant differ-
ences in objectively measured sleep latency, sleep efﬁciency, and
sleep duration between girls ages 11–12 years with and without
insomnia symptoms, while no PSG differences were found between
boys with and without insomnia symptoms in the 11- to 12-year
age range. Given that the onset of puberty occurs earlier in girls
than in boys, together, these ﬁndings suggest that the increased
prevalence of insomnia symptoms associated with objective sleep
disturbances in preadolescent girls may be driven by hormonal
changes occurring at the onset of puberty [4,8], rather than anxiety
and depression per se. In fact, it is likely that insomnia symptoms
associated with objective sleep disturbance in girls during the peri-
pubertal stage of development may confer a risk factor for future
onset of anxiety or depression. Another possible explanation for
the increase in prevalence of insomnia in girls ages 11–12 years
may be partially explained by a shift in circadian preference to-
wards eveningness [36]. However, the fact that PSG deﬁned sleep
disturbances were found in girls ages 11–12 years and that they
complained of both DFA and DSA indicates that the peak in insom-
nia symptoms in this age group is not just as a result of delayed
sleep phase preference.
Finally, our study showed a lack of association between insom-
nia symptoms and SDB in a population-based sample of young
children and preadolescents. In fact, the prevalence of insomnia
symptoms remained similar after the exclusion of children with
SDB, and interestingly the association between insomnia symp-
toms and EDS became non signiﬁcant. These ﬁndings suggest that
EDS is more closely linked to SDB through its association with
obesity [22,28,29] than with insomnia symptoms, as in older ado-
lescents and adults [13,14,37].
Several limitations should be considered when interpreting the
results of our study. First, the objective sleep ﬁndings should be
considered within the context of limitations that include the pos-
sible impact of the ﬁrst-night effect. Future population-based stud-
ies should explore the use of multiple PSG nights or less expensive
objective measures of habitual sleep, e.g., actigraphy. Second, the
deﬁnition of insomnia was that of symptoms rather than a disorder
or syndrome, as it did not include diagnostic criteria for behavioral
insomnia of childhood. Future large, epidemiologic studies should
use current diagnostic criteria for childhood insomnia and its sub-
types. Third, we did not present a more detailed analysis of the
electroencephalogram such as spectral analysis which could aid
in explaining the increased prevalence of insomnia symptoms.
Lastly, we did not collect data on pubertal status, and thus were
not able to examine the effects of pubertal developmental status
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prevalence of insomnia symptoms increases in boys at a similar
peripubertal stage. Despite these limitations, our study extends
the limited previous knowledge on insomnia symptoms in young
children by showing that the prevalence of insomnia symptoms
peaks in girls ages 11–12 years is associated with objective sleep
disturbances and may be related to hormonal changes associated
with the onset of puberty rather than anxiety and depression per
se. Furthermore, our study provides evidence that SDB does not
signiﬁcantly contribute to prevalent insomnia symptoms in
children.
It is likely that multiple factors in the child, parent, family, and
environment interacting overtime contribute to the development
and maintenance of insomnia in children. These data have impor-
tant implications for primary care physicians and pediatricians
who generally are aware of sleep issues in infants and toddlers,
but often fail to adequately screen young school-aged and preado-
lescent children for sleep problems in the clinical setting [38]. Gi-
ven the high prevalence of insomnia symptoms in young children,
the likelihood of the symptoms to persist over time [39], and the
growing evidence on the importance of sleep in childhood health,
future studies need to examine the physical and mental health
consequences of insomnia in children.
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